Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xin Yu Li

Showing results (11-20 of 358) with videos related to

Pageof 36
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 9, 2021
[Reaserch Advances in the Treatment of Primary Immune Thrombocytopenia--Review]Xin-Yu Li, Yang He, Chang-Geng Ruan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2018
A ROADMAP Plan to Address Research Needs for Gonococcal Antimicrobial Resistance in ChinaXiang-Sheng Chen, Yue-Ping Yin, Xin-Yu Li
Frontiers in Oncology|February 3, 2025
Retrospective analysis of 1539 nasopharyngeal carcinoma cases: chemotherapy should not be excluded for non-Asian patients with T1-2N1M0 stageXin-Yu Li, Chang-Ying Zhong, Hui-Xian Xu
Discover Oncology|March 19, 2026
A bibliometric analysis of the role of apoptosis in breast cancer immunotherapy from 1994 to 2024Xin-Yu Li, Shan-Qi Li, Xiao-Yi Wang
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|May 30, 2008
[Characteristics of poloxamer thermosensitive in situ gel of dexamethasone sodium phosphate]Xin-Yu Li, Zhao-Jing Zhu, An-Yuan Cheng
Frontiers in Public Health|April 10, 2025
Urinary metal levels and their association with Parkinson's disease risk: insights from NHANES 2013-2020Jia-Jie Lv, Xin-Yu Li, Cheng-Hao Yang
Frontiers in Neurology|January 8, 2024
Temporal trends of migraine and tension-type headache burden across the BRICS: implications from the Global Burden of Disease study 2019Yuan-Jie Zhang, Xin-Yu Li, Zhi-Lin Guo
Trends in Molecular Medicine|May 30, 2020
Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic OpportunitiesLei Meng, Xin-Yu Li, Liang Shen, et al.
Life Sciences|October 22, 2022
Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat dietSai Wang, Xin-Yu Li, Hong-Fang Ji, et al.
Applied Microbiology and Biotechnology|June 26, 2019
Regulation of gut microbiota in Alzheimer's disease mice by silibinin and silymarin and their pharmacological implicationsLiang Shen, Lu Liu, Xin-Yu Li, et al.
Pageof 36

Showing results (11-20 of 358) with videos related to

Sort By:
Pageof 36
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 9, 2021
[Reaserch Advances in the Treatment of Primary Immune Thrombocytopenia--Review]Xin-Yu Li, Yang He, Chang-Geng Ruan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2018
A ROADMAP Plan to Address Research Needs for Gonococcal Antimicrobial Resistance in ChinaXiang-Sheng Chen, Yue-Ping Yin, Xin-Yu Li
Frontiers in Oncology|February 3, 2025
Retrospective analysis of 1539 nasopharyngeal carcinoma cases: chemotherapy should not be excluded for non-Asian patients with T1-2N1M0 stageXin-Yu Li, Chang-Ying Zhong, Hui-Xian Xu
Discover Oncology|March 19, 2026
A bibliometric analysis of the role of apoptosis in breast cancer immunotherapy from 1994 to 2024Xin-Yu Li, Shan-Qi Li, Xiao-Yi Wang
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|May 30, 2008
[Characteristics of poloxamer thermosensitive in situ gel of dexamethasone sodium phosphate]Xin-Yu Li, Zhao-Jing Zhu, An-Yuan Cheng
Frontiers in Public Health|April 10, 2025
Urinary metal levels and their association with Parkinson's disease risk: insights from NHANES 2013-2020Jia-Jie Lv, Xin-Yu Li, Cheng-Hao Yang
Frontiers in Neurology|January 8, 2024
Temporal trends of migraine and tension-type headache burden across the BRICS: implications from the Global Burden of Disease study 2019Yuan-Jie Zhang, Xin-Yu Li, Zhi-Lin Guo
Trends in Molecular Medicine|May 30, 2020
Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic OpportunitiesLei Meng, Xin-Yu Li, Liang Shen, et al.
Life Sciences|October 22, 2022
Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat dietSai Wang, Xin-Yu Li, Hong-Fang Ji, et al.
Applied Microbiology and Biotechnology|June 26, 2019
Regulation of gut microbiota in Alzheimer's disease mice by silibinin and silymarin and their pharmacological implicationsLiang Shen, Lu Liu, Xin-Yu Li, et al.
Pageof 36